O143 Baseline characteristics of patients, with or without MRSA, in two double-blind, randomised, multinational, Phase 3 studies comparing telavancin with vancomycin for the treatment of complicated skin and skin structure infections
Publication
, Conference
Corey, GR; Stryjewski, ME; Fowler, VG; Lentnek, A; Hopkins, A; Kitt, MM; Barriere, SL
Published in: International Journal of Antimicrobial Agents
March 2007
Duke Scholars
Published In
International Journal of Antimicrobial Agents
DOI
ISSN
0924-8579
Publication Date
March 2007
Volume
29
Start / End Page
S29 / S29
Publisher
Elsevier BV
Related Subject Headings
- Microbiology
- 3207 Medical microbiology
- 3107 Microbiology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1108 Medical Microbiology
Citation
APA
Chicago
ICMJE
MLA
NLM
Corey, G. R., Stryjewski, M. E., Fowler, V. G., Lentnek, A., Hopkins, A., Kitt, M. M., & Barriere, S. L. (2007). O143 Baseline characteristics of patients, with or without MRSA, in two double-blind, randomised, multinational, Phase 3 studies comparing telavancin with vancomycin for the treatment of complicated skin and skin structure infections. In International Journal of Antimicrobial Agents (Vol. 29, pp. S29–S29). Elsevier BV. https://doi.org/10.1016/s0924-8579(07)70093-6
Corey, G. R., M. E. Stryjewski, V. G. Fowler, A. Lentnek, A. Hopkins, M. M. Kitt, and S. L. Barriere. “O143 Baseline characteristics of patients, with or without MRSA, in two double-blind, randomised, multinational, Phase 3 studies comparing telavancin with vancomycin for the treatment of complicated skin and skin structure infections.” In International Journal of Antimicrobial Agents, 29:S29–S29. Elsevier BV, 2007. https://doi.org/10.1016/s0924-8579(07)70093-6.
Corey GR, Stryjewski ME, Fowler VG, Lentnek A, Hopkins A, Kitt MM, et al. O143 Baseline characteristics of patients, with or without MRSA, in two double-blind, randomised, multinational, Phase 3 studies comparing telavancin with vancomycin for the treatment of complicated skin and skin structure infections. In: International Journal of Antimicrobial Agents. Elsevier BV; 2007. p. S29–S29.
Corey, G. R., et al. “O143 Baseline characteristics of patients, with or without MRSA, in two double-blind, randomised, multinational, Phase 3 studies comparing telavancin with vancomycin for the treatment of complicated skin and skin structure infections.” International Journal of Antimicrobial Agents, vol. 29, Elsevier BV, 2007, pp. S29–S29. Crossref, doi:10.1016/s0924-8579(07)70093-6.
Corey GR, Stryjewski ME, Fowler VG, Lentnek A, Hopkins A, Kitt MM, Barriere SL. O143 Baseline characteristics of patients, with or without MRSA, in two double-blind, randomised, multinational, Phase 3 studies comparing telavancin with vancomycin for the treatment of complicated skin and skin structure infections. International Journal of Antimicrobial Agents. Elsevier BV; 2007. p. S29–S29.
Published In
International Journal of Antimicrobial Agents
DOI
ISSN
0924-8579
Publication Date
March 2007
Volume
29
Start / End Page
S29 / S29
Publisher
Elsevier BV
Related Subject Headings
- Microbiology
- 3207 Medical microbiology
- 3107 Microbiology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1108 Medical Microbiology